Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

J. B. Ravzatov

7 та иш

Andijan State Medical Institute

  1. Parameters of blood short-chain peptides and digestive hydrolases in patients with chronic hepatitis B virus infection

    M. A. Zhuraeva, Владимир Алексеевич Алейник, N. D. Ashuralieva +3

    МақолаNeuropeptides and Animal PhysiologyRussian Journal of Infection and Immunity20210 иқтибос
    ABI

  2. PREVALENCE AND CAUSES OF LIVER CIRRHOSIS IN DIFFERENT REGIONS LITERATURE REVIEW

    J. B. Ravzatov, Dildora Abdumalikovna Nabieva

    МақолаLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  3. PREVALENCE AND CAUSES OF LIVER CIRRHOSIS IN DIFFERENT REGIONS LITERATURE REVIEW

    J. B. Ravzatov, Dildora Abdumalikovna Nabieva

    МақолаLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  4. PROGNOSTIC SIGNIFICANCE OF IMMUNOGENETIC MARKERS IN THE EARLY ASSESSMENT OF DECOMPENSATION RISK IN LIVER CIRRHOSIS

    Boburjon Rasulov, J. B. Ravzatov

    МақолаLiver Disease and TransplantationZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  5. HORMONAL AND GENETIC MECHANISMS OF METABOLIC-ASSOCIATED STEATOTIC LIVER DISEASE IN WOMEN OF REPRODUCTIVE AGE

    Dilfuza Yunusova, J. B. Ravzatov

    МақолаLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  6. HORMONAL AND GENETIC MECHANISMS OF METABOLIC-ASSOCIATED STEATOTIC LIVER DISEASE IN WOMEN OF REPRODUCTIVE AGE

    Dilfuza Yunusova, J. B. Ravzatov

    МақолаLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  7. PROGNOSTIC SIGNIFICANCE OF IMMUNOGENETIC MARKERS IN THE EARLY ASSESSMENT OF DECOMPENSATION RISK IN LIVER CIRRHOSIS

    Boburjon Rasulov, J. B. Ravzatov

    МақолаLiver Disease and TransplantationZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI